SIR -Your Editorial 'Who are we? ' (Nature 453, 563; 2008) warns that research into the human microbiome should not be oversold until medical promise is established. Fads, hype and false promises have no place in any research, but neither should we bias debate by suppressing reasonable extrapolation.
We were led to believe, wrongly, that genome sequences would open our eyes and we would understand -but that did not reduce the value of those sequences in the slightest. They are more valuable than expected precisely because we did not understand them as expected. Research showing us that we do not comprehend what seems to be obvious can be important. Unfortunately, it is the most difficult to conceive, justify, fund and publish because, until we do, we think its premises are wrong.
Decisions on whether to fund particular projects are not scientific decisions. They are social decisions, and may therefore be over-influenced by hype. Research funding must compete with other funding needs, and research hype is up against the hype of military spending, spiralling oil costs and the latest celebrity exploits. Waiting for medical benefits to be proven before funding basic research would mean that basic research would never be funded.
Medicine is founded on germ theory, physiology, hygiene and antibiotics. Yet there are profound gaps in our understanding of those interactions. Health conditions common in the developed world (obesity, diabetes, allergies, asthma, heart, vascular and inflammatory diseases) remain rare to nonexistent in the rural undeveloped world, despite the lack of potential treatment. The 'hygiene hypothesis' tries to explain these differences, but so far no protective agent has been found. If the microbiome project can eventually deliver such an agent, or agents, and stop even a fraction of the health decline associated with economic development, the effects will still be profound.
The analogy of the microbiome with rainforest biodiversity is apt. We should exhaustively sample and understand the diversity of both in the wild before the 'clear cutting' of modern agriculture and hygiene practices irreversibly destroys them both. 578-580; 2008) highlights the potential importance of the gut microbiome in understanding health. As you discuss, human profiles differ in obese and lean individuals and are being scrutinized for their possible influence on weight.
David
A factor you don't mention is the routine administration over some 50 years of antibiotics and probiotics as growth promoters to farm animals. Use of antibiotics for this purpose was banned in 2005 in the European Union, but it continues in many places (including the United States).
Compounds with antibiotic activity and bacteria with probiotic activity have been widely tested as growth promoters (see, for example, M. Khan et al. Brit. Poultry Sci. 48, 732-735; 2007 and Bifidobacterium species. Humans, particularly children, have been taking these same probiotics for many years, especially in fermented diary products. They also frequently take broad-spectrum antibiotics.
Given the current obesity pandemic among humans and the impact of antimicrobials on weight gain in animals such as poultry and pigs, there may be a case for evaluating the effects of routinely adding bacteria to our food and of long-term consumption of antibiotics. But even this number falls short by comparison with the alphabets of the many consonantrich languages of the northern Caucasus. These commonly have more than 40 letters (for example, there are 45 in Lezghin, 49 in Chechen, 51 in Avar and 62 in one of the dialects of Abkhaz).
Didier Raoult
The outright winner is the Archi alphabet, developed in 2006. This is another language from the Caucasus and has 97 letters -although many of these are groups of two, three or even four or five characters, rather than independent signs. The highest number of independent signs, at 41, is probably to be found in Abkhaz. The 30% increase in MRC funding over the current spending-review period includes a specific allocation for translational research. However, it also features increased funds for more basic studies. The only significant change for basic researchers is that it will be much easier for them to contribute to translational research and to work related to public health if they wish to do so.
Mikhail S. Gelfand
The MRC has always recognized that giving talented investigators scope to pursue their ideas is one of the best ways to advance medical science. It will shortly be announcing the reintroduction of five-yearprogramme grants to improve support for longer-term research and risk-taking.
The council will continue to support a vibrant and wellresourced science base, acknowledging that investigatorled research, championed within the MRC and throughout the research community, is fundamental to what the MRC does. Our research relies on a widely used model of allergic lung inflammation, in which mice are exposed to a model allergen. While we were working at the University of Cambridge, the model was always reproducible. But when we returned to Ireland to continue this research, we found the lung physiology of the control mice was inexplicably abnormal for the first year.
Leszek Borysiewicz
After months of revising protocols, testing reagents and pathogen screening, we noticed that all the mice developed spontaneous, non-specific lung inflammation within four weeks of arrival, indicating that an environmental factor was probably to blame.
To cut a long story short, it turned out that mouse chow sterilized by steam autoclaving caused the release of fine particulates, and these were inhaled by mice in their individually ventilated cages. Mice fed instead with irradiated chow had normal lungs.
Unless peer-reviewed and published, such discoveries become anecdotal. So why did we not publish these findings? After a two-year hiatus doing experiments outside the area of our core research, the pressure was on to focus once more on our research aims. Additionally, the growing emphasis on commercially exploitable research, rather than on basic science, means that funding bodies are not impressed by publications on empirical investigations.
This raises a broader, unspoken question in the field of mouse immunology. Why are there differences between data generated by different groups working on apparently the same mouse model or strain? 
